Shivam et al. 2022. A COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF TENELIGLIPTIN VERSUS GLIMEPIRIDE AS AN ADD-ON THERAPY TO METFORMIN MONO-THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. Journal of the ASEAN Federation of Endocrine Societies. 34, 2 (May 2022), 26.